Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia.
about
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patientsThe treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials.Revealing the Effects of the Herbal Pair of Euphorbia kansui and Glycyrrhiza on Hepatocellular Carcinoma Ascites with Integrating Network Target Analysis and Experimental ValidationEffect of Glycyrrhiza on the Diuretic Function of Euphorbia kansui: An Ascites Mouse ModelImplications of Hyponatremia in Liver TransplantationTolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trial.Correlation between changes in bodyweight and changes in ascites volume in liver cirrhosis patients with hepatic edema in short-term diuretic therapy.
P2860
Q26778032-3FDD666F-BD7A-42F6-9D95-5C84009867CDQ34093932-D32EF400-F722-4F48-9F15-BB1D558C28CDQ35657152-B4E40DA0-3DE0-46A1-BDAB-0DB47B6F7D19Q36855036-1D9A034A-C9F8-4320-8D82-B7E46A646975Q36924811-81AABACD-C76E-4135-B510-AE7C4B8D0345Q42087113-1E3DDE7A-04D3-458F-A160-56F7A415428CQ45107672-EA123E17-37F7-4C69-9175-CCEA57DC4933Q51211871-B81631F3-ADFA-4E4B-9CE8-6A9B718CFA45
P2860
Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia.
@en
type
label
Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia.
@en
prefLabel
Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia.
@en
P2860
P356
P1476
Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia.
@en
P2093
Shahid Habib
Thomas D Boyer
P2860
P304
P356
10.1177/1756283X12437357
P577
2012-05-01T00:00:00Z